Combination tacrolimus and ustekinumab therapy is effective in inducing clinical, biochemical and endoscopic remission in refractory moderate to severe ulcerative colitis

被引：3
|
作者：
Gupta, Rachit [1 ]
Schulberg, Julien D. [1 ]
Niewiadomski, Ola [1 ]
Wright, Emily K. [1 ]
机构：
[1] St Vincents Hosp Melbourne Pty Ltd, Gastroenterol, 41 Victoria Parade, Fitzroy, 3065, Australia
来源：
AUTOIMMUNITY REVIEWS | 2022年 / 21卷 / 07期
关键词：
D O I：
10.1016/j.autrev.2022.103115
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Medium to long-term efficacy and safety of oral tacrolimus in moderate to severe steroid refractory ulcerative colitis
    Vicente Olmedo-Martin, Raul
    Amo-Trillo, Victor
    Gonzalez-Grande, Rocio
    Jimenez-Perez, Miguel
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2017, 109 (08) : 559 - 565
  • [42] Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
    Sandborn, William J.
    Feagan, Brian G.
    Marano, Colleen
    Zhang, Hongyan
    Strauss, Richard
    Johanns, Jewel
    Adedokun, Omoniyi J.
    Guzzo, Cynthia
    Colombel, Jean-Frederic
    Reinisch, Walter
    Gibson, Peter R.
    Collins, Judith
    Jarnerot, Gunnar
    Hibi, Toshifumi
    Rutgeerts, Paul
    GASTROENTEROLOGY, 2014, 146 (01) : 85 - 95
  • [43] GRANULO-MONOCYTOAPHERESIS IS MORE EFFECTIVE IN INDUCING AND MAINTAINING CLINICAL RESPONSE IN MILD ULCERATIVE COLITIS THAN IN MODERATE TO SEVERE DISEASE
    De Cassan, C.
    Savarino, E. V.
    Marson, P.
    Hatem, G.
    Sturniolo, G. C.
    D'Inca, R.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : S74 - S74
  • [44] Induction of remission in moderate-to-severe steroid refractory ulcerative colitis using patient-driven non-pharmacologic therapy
    Lee, Alice M.
    Mandaliya, Rohan
    Mattar, Mark C.
    ADVANCES IN INTEGRATIVE MEDICINE, 2018, 5 (03) : 119 - 121
  • [45] Efficacy of Tacrolimus in Patients With Active Ulcerative Colitis Refractory to Corticosteroids After Failure of Infliximab Remission Induction Therapy
    Takeuchi, Ken
    Yamada, Akihiro
    Suzuki, Yasuo
    GASTROENTEROLOGY, 2013, 144 (05) : S206 - S206
  • [46] Maintenance therapy of vedolizumab (VDZ) after induction of remission by tacrolimus (TAC) in patients with refractory ulcerative colitis (UC)
    Ito, A.
    Shun, M.
    Teppei, O.
    Katsutoshi, T.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S377 - S378
  • [47] Induction of Remission by Infliximab and Maintenance by Azathioprine : An Effective Strategy in Moderately Severe Steroid Refractory Ulcerative Colitis
    Mahajan, Ramit
    Singh, Arshdeep
    Midha, Vandana
    Sood, Ajit
    Kaur, Kirandeep
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 182 - 182
  • [48] Long-term outcomes of cyclosporin induction and ustekinumab maintenance combination therapy in patients with steroid-refractory acute severe ulcerative colitis
    Vitali, Francesco
    Rath, Timo
    Klenske, Entcho
    Voegele, Anna-Lena
    Ganzleben, Ingo
    Zundler, Sebastian
    Strobel, Deike
    Geppert, Carol
    Hartmann, Arndt
    Neurath, Markus F.
    Atreya, Raja
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2024, 17
  • [49] Bridging therapy with infliximab to immunomodulators is effective in severe, steroid-refractory ulcerative colitis
    Holt, D. Q.
    Hair, C.
    Moore, G. T.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A312 - A312
  • [50] Induction of remission with tacrolimus in a patient with severe acute, cortisone refractory ulcerative colitis and severe Covid-19 pneumonia: a case report
    Rieker, Lisanne
    Hofer, Johannes
    Petzold, Golo
    Ellenrieder, Volker
    Amanzada, Ahmad
    BMC GASTROENTEROLOGY, 2022, 22 (01)
12345